A carregar...
The Effect of Hydroxyurea Therapy in Bahraini Sickle Cell Disease Patients
Hydroxyurea (HU) is used as a disease-modifying agent in sickle cell disease (SCD). Its beneficial effects have been ascribed to inhibition of the sickling process through increase of fetal hemoglobin (HbF) levels and influence on multiple factors affecting adhesion of erythrocytes to vascular endot...
Na minha lista:
| Publicado no: | Indian J Hematol Blood Transfus |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer India
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4733670/ https://ncbi.nlm.nih.gov/pubmed/26855516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-015-0529-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|